Genopathy
Gene-Disorder Association · Article
Gene
CERS2
Ceramide Synthase 2
Disorder
Myoclonic Epilepsy Of Unverricht And Lundborg
First reported 1951
Key publication · disorder Familial degeneration of the cerebral gray matter in childhood with convulsions, myoclonus, spasticity, cerebellar ataxia, choreoathetosis, dementia, and death in status epilepticus; differentiation of infantile and juvenile types.The Journal of pediatrics · 1951
Manually curated
Association Review

In brief

The association between CERS2 (Ceramide Synthase 2) and Myoclonic Epilepsy Of Unverricht And Lundborg is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 28
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CERS2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Myoclonic Epilepsy Of Unverricht And Lundborg

The disorder

14 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

16 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Provenance

References & sources

7 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access